- Home
- DYN vs PHR Comparison
DYN vs PHR Comparison
Compare DYN & PHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- PHR
- Stock Information
- Founded
- DYN 1984
- PHR 2005
- Country
- DYN United States
- PHR United States
- Employees
- DYN N/A
- PHR N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- PHR Business Services
- Sector
- DYN Health Care
- PHR Consumer Discretionary
- Exchange
- DYN Nasdaq
- PHR Nasdaq
- Market Cap
- DYN 1.4B
- PHR 1.5B
- IPO Year
- DYN 2020
- PHR 2019
- Fundamental
- Price
- DYN $12.50
- PHR $27.88
- Analyst Decision
- DYN Strong Buy
- PHR Strong Buy
- Analyst Count
- DYN 15
- PHR 13
- Target Price
- DYN $36.00
- PHR $31.77
- AVG Volume (30 Days)
- DYN 3.0M
- PHR 496.1K
- Earning Date
- DYN 07-28-2025
- PHR 09-04-2025
- Dividend Yield
- DYN N/A
- PHR N/A
- EPS Growth
- DYN N/A
- PHR N/A
- EPS
- DYN N/A
- PHR N/A
- Revenue
- DYN N/A
- PHR $434,532,000.00
- Revenue This Year
- DYN N/A
- PHR $14.74
- Revenue Next Year
- DYN N/A
- PHR $11.57
- P/E Ratio
- DYN N/A
- PHR N/A
- Revenue Growth
- DYN N/A
- PHR 16.29
- 52 Week Low
- DYN $6.36
- PHR $17.07
- 52 Week High
- DYN $47.45
- PHR $30.53
- Technical
- Relative Strength Index (RSI)
- DYN 70.49
- PHR 55.93
- Support Level
- DYN $10.78
- PHR $26.75
- Resistance Level
- DYN $12.59
- PHR $28.71
- Average True Range (ATR)
- DYN 0.82
- PHR 1.01
- MACD
- DYN 0.31
- PHR 0.14
- Stochastic Oscillator
- DYN 78.35
- PHR 77.91
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About PHR Phreesia Inc.
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.